Founded in 2003, Touchstone International Medical Science Co., Ltd. (Touchstone) was listed on the Shanghai Stock Exchange in September 2020. Touchstone specializes in the development of advanced and innovative surgical staplers that enhance clinical performance, minimize risk and improve patient outcomes. Touchstone bridges science with technology and design to deliver patient-centric surgical solutions for the operating room.
Touchstone's product portfolio includes: Intraluminal Stapler for Single Use, Endoscopic Linear Cutter and Single Use Loading Unit，Linear Cutter and Reloads, Auto Purse String Clamp for Single Use，Linear Stapler and Reloads. All products are used worldwide in both laparoscopic and open surgery, covering Thoracic, Gastrointestinal, Hepatobiliary, Splenic and Pancreatic, General and Urology.
Touchstone's highly skilled professionals and engineers work closely with surgeons from all over the world, designing effective and innovative solutions to the challenges they face in their surgical practice. Maintaining a large patent portfolio Touchstone strives to build a comprehensive Intellectual Property base. By the end of 2019, 380 patents have been granted in China, Europe, USA and Japan.
The Company's products have passed medical device regulatory approvals worldwide, including CE in EU, FDA in the USA, TGA in Australia, KFDA in Korea and Anvisa in Brazil. The company has complete control over its supply chain and quality assurance processes.
Touchstone aims to continue in developing quality surgical staplers with clinical advantages, and is committed to becoming an innovative production powerhouse for advanced surgical staplers.
| Full name | TOUCHSTONE INTERNATIONAL MEDICAL SCIENCE CO.,LTD. |
|---|---|
| Abbreviations | TOUCHSTONE |
| Code | 688013 |
| Founded | August 18, 2003 |
| Listing | September 28, 2020 |
| Domicile | Suzhou |
| tsbs@touchstone.hk | |
| STAR Theme | Biomedicine |
| CSRCSector | Manufacturing |
| Has weighted voting rights structure? | No |
| 2020 | 2019 | 2018 | |
|---|---|---|---|
| Earnings Per Share | 0.54 | 0.70 | 0.39 |
| R&D expenditure as a % of operating revenue | 9.41% | 8.16% | 8.93% |
| Operating Revenue | 163.34 | 172.76 | 119.03 |
| Net Income | 34.95 | 42.01 | 23.13 |
| 2020 | 2019 | 2018 | |
|---|---|---|---|
| Operating Revenue | 163.34 | 172.76 | 119.03 |
| Operating Costs | 131.76 | 127.70 | 95.44 |
| Operating Income | 34.35 | 45.15 | 23.80 |
| Pretax Income | 40.20 | 48.60 | 27.16 |
| Income Tax | 5.25 | 6.59 | 4.03 |
| Net Income | 34.95 | 42.01 | 23.13 |
| 2020 | 2019 | 2018 | |
|---|---|---|---|
| Assets | |||
| Current Assets-Total | 410.29 | 49.45 | 43.14 |
| Non-current Assets-Total | 74.96 | 75.46 | 73.81 |
| Total Assets | 485.24 | 124.91 | 116.95 |
| Liabilities | |||
| Current Liabilities-Total | 17.82 | 16.64 | 32.64 |
| Non-current Liabilities-Total | 1.53 | 1.08 | 1.41 |
| Total Liabilities | 19.35 | 17.72 | 34.05 |
| Stockholder's Equity | |||
| Share Capital | 80.00 | 60.00 | 43.67 |
| Retained Profits | 31.47 | 0.18 | 6.23 |
| Total Owners' Equity | 465.89 | 107.18 | 82.90 |
| 2020 | 2019 | 2018 | |
|---|---|---|---|
| Net Cash Flows-Operating | 42.08 | 34.82 | 34.44 |
| Net Cash Flows-Investing | -257.10 | -5.89 | -23.68 |
| Net Cash Flows-Financing | 321.19 | -29.75 | -9.01 |
| Name | No. of Shares Held (mn) | % of Shares Held |
|---|---|---|
| Jason Chen | 20.95 | 26.19% |
| Ben Chen | 20.93 | 26.17% |
| Inspire Surgical Limited | 7.79 | 9.74% |
| Vivian Liu | 4.70 | 5.87% |
| Suzhou Sheng Quan Hai Cheng Venture Capital Investment LLP | 2.72 | 3.40% |
| Kunshan Fen Xiang Investment LLP | 2.69 | 3.36% |
| 周信钢 | 1.93 | 2.42% |
| 中国中金财富证券有限公司 | 1.87 | 2.34% |
| 安信证券投资有限公司 | 0.92 | 1.15% |
| 周晨 | 0.67 | 0.83% |
All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.
Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.
Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.